Search results for "Bow"

showing 10 items of 1006 documents

Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases.

2015

Background and Aims: The clinical use of azathioprine and 6-mercaptopurine is limited by their delayed onset of action and potential side effects such as myelosuppression and hepatotoxicity. As these drugs specifically target the Vav1/Rac1 signalling pathway in T lamina propria lymphocytes via their metabolite 6-thio-GTP, we studied expression and optimised suppression of this pathway in inflammatory bowel diseases [IBD]. Methods: Rac1 and Vav1 expressions were analysed in mucosal immune cells in IBD patients. Targeted molecular modelling of the 6-thio-GTP molecule was performed to optimise Rac1 blockade; 44 modified designer thiopurine-analogues were tested for apoptosis induction, potenti…

0301 basic medicinerac1 GTP-Binding Proteinmedicine.medical_treatmentT-LymphocytesAzathioprineApoptosisInflammatory bowel diseaseDesigner Drugs03 medical and health sciences0302 clinical medicineImmune systemIntestinal mucosamedicineHumansIntestinal MucosaProto-Oncogene Proteins c-vavLamina propriaThiopurine methyltransferasebiologybusiness.industryMercaptopurineGastroenterologyImmunosuppressionGeneral Medicinemedicine.diseaseInflammatory Bowel Diseases030104 developmental biologymedicine.anatomical_structureApoptosisCase-Control StudiesDrug DesignImmunologybiology.protein030211 gastroenterology & hepatologybusinessBiomarkersImmunosuppressive Agentsmedicine.drugSignal TransductionJournal of Crohn'scolitis
researchProduct

Robotic Rehabilitation and Multimodal Instrumented Assessment of Post-stroke Elbow Motor Functions-A Randomized Controlled Trial Protocol.

2020

Background: The reliable assessment, attribution, and alleviation of upper-limb joint stiffness are essential clinical objectives in the early rehabilitation from stroke and other neurological disorders, to prevent the progression of neuromuscular pathology and enable proactive physiotherapy toward functional recovery. However, the current clinical evaluation and treatment of this stiffness (and underlying muscle spasticity) are severely limited by their dependence on subjective evaluation and manual limb mobilization, thus rendering the evaluation imprecise and the treatment insufficiently tailored to the specific pathologies and residual capabilities of individual patients. Methods: To ad…

030506 rehabilitationmedicine.medical_specialtyModified Ashworth scaleElbowPowered exoskeletonstroke robotic rehabilitation instrumented spasticity assessment exoskeleton upper limb joint stiffness functional rehabilitationupper limblcsh:RC346-429instrumented spasticity assessmentlaw.inventionstiffness03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled triallawjointmedicineSpasticityrobotic rehabilitationStrokelcsh:Neurology. Diseases of the nervous systembusiness.industryexoskeletonjoint stiffnessmedicine.diseaseClinical Trialstroke3. Good healthClinical trialbody regionsfunctional rehabilitationHemiparesismedicine.anatomical_structureNeurologyNeurology (clinical)medicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgeryFrontiers in neurology
researchProduct

Typical symptom change patterns and their predictors in patients with social anxiety disorder: A latent class analysis

2020

Abstract Objectives The use of trajectories and analysis of change patterns is a promising way toward better differentiation of subgroups in psychotherapy studies. Research on change patterns in social anxiety disorder (SAD) are still rare, although SAD is one of the most common mental disorders. In a secondary analysis of data from the SOPHO-NET-trial (ISRCTN53517394) this study aimed to investigate change patterns and their predictors in a sample of SAD patients. Methods Patients with SAD (N = 357) were randomly assigned to cognitive-behavioral or psychodynamic therapy. The Liebowitz Social Anxiety Scale (LSAS) was assessed at 1st session (pre), 8th session, 15th session and at the end of…

050103 clinical psychologyPsychodynamic psychotherapy05 social sciencesSocial anxietyChange patternsPhobia SocialLiebowitz social anxiety scaleAnxietyLogistic regressionAnxiety DisordersLatent class model030227 psychiatry3. Good healthPsychotherapy03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicineLatent Class AnalysisSecondary analysisHumans0501 psychology and cognitive sciencesIn patientPsychologyClinical psychologyJournal of Anxiety Disorders
researchProduct

Baseline Patient Characteristics Predicting Outcome and Attrition in Cognitive Therapy for Social Phobia: Results from a Large Multicentre Trial

2014

We examined the role of baseline patient characteristics as predictors of outcome (end-state functioning, response and remission) and attrition for cognitive therapy (CT) in social anxiety disorder (SAD). Beyond socio-demographic and clinical variables such as symptom severity and comorbidity status, previously neglected patient characteristics (e.g., personality, self-esteem, shame, interpersonal problems and attachment style) were analysed. Method Data came from the CT arm of a multicentre RCT with n = 244 patients having DSM-IV SAD. CT was conducted according to the manual by Clark and Wells. Severity of SAD was assessed at baseline and end of treatment with the Liebowitz Social Anxiety …

050103 clinical psychologymedicine.medical_specialtymedicine.medical_treatmentmedia_common.quotation_subjectLiebowitz social anxiety scaleLogistic regressionlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawAttachment theorymedicinePersonality0501 psychology and cognitive sciencesPsychiatrymedia_common05 social sciencesSocial anxietymedicine.diseaseComorbidity030227 psychiatryClinical PsychologyCognitive therapyPsychologyClinical psychologyClinical Psychology & Psychotherapy
researchProduct

The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists

2021

2019-20 coronavirus outbreakHepatologyCoronavirus disease 2019 (COVID-19)Adrenal cortex hormonesbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GastroenterologyInflammatory Bowel Diseasesmedicine.diseaseInflammatory bowel diseaseTnf antagonistsImmunologymedicinebusinessGastroenterology
researchProduct

Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Cross-sectional studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Directive CounselingInternal medicineHumansImmunology and AllergyMedicineFamilyPhysician's RoleLetter to the EditorAcademicSubjects/MED00260Ibdjnl/1SARS-CoV-2business.industryGastroenterologistsVaccinationAge FactorsGastroenterologyCOVID-19Inflammatory Bowel DiseasesPatient Acceptance of Health CareInflammatory Bowel DiseasesVaccinationItalyInfluenza VaccinesCohortbusinessAttitude to HealthInflammatory Bowel Diseases
researchProduct

P463 COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey…

2021

Abstract Background Vaccine hesitancy, the delay in acceptance or refusal of vaccination despite its availability, represents a threat to the diffusion and lethality of infectious diseases. COVID-19 vaccination has been recommended by national and international organizations in patients with Inflammatory Bowel Diseases (IBD). The aim of the study was to evaluate COVID-19 vaccine willingness and hesitancy in a population of Italian patients with IBD, and their determinants. Methods In February 2021 an online questionnaire focused on COVID-19 vaccine was proposed to a representative sample of Italian IBD patients. Socio-demographic characteristics, IBD features, lifestyle, perception of COVID…

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryGastroenterologyInflammatory Bowel DiseasesGeneral MedicineClinical: Therapy and Observationmedicine.diseaseInflammatory bowel diseasePoster presentationsVaccinationVaccination RefusalFamily medicineMedicineIn patientAdverse effectbusinessAcademicSubjects/MED00260Journal of Crohn's & Colitis
researchProduct

Intestinal tuberculosis in a child living in a country with a low incidence of tuberculosis : a case report

2014

Background: Relatively common in adults, intestinal tuberculosis is considered rare in children and adolescents. The protean manifestations of intestinal tuberculosis mean that the diagnosis is often delayed (sometimes even for years), thus leading to increased mortality and unnecessary surgery. The main diagnostic dilemma is to differentiate intestinal tuberculosis and Crohn’s disease because a misdiagnosis can have dramatic consequences. Case presentation: A 13-year-old Caucasian, Italian female adolescent attended the Emergency Department complaining of abdominal pain, a fever of up to 38°C, night sweats, diarrhea with blood in stool, and a weight loss of about three kilograms over the p…

Abdominal painBiopsymedicine.medical_treatmentAntitubercular AgentsCase ReportInflammatory bowel diseaseGastroenterologySettore MED/38 - Pediatria Generale E SpecialisticaCrohn DiseaseLaparotomyWhole Body ImagingMedicine(all)biologymedicine.diagnostic_testIleal DiseasesIncidenceGeneral MedicineEmerging infectionsTreatment OutcomeItalyIntestinal tuberculosisAbdominal ultrasonographyDrug Therapy CombinationFemalemedicine.symptommedicine.medical_specialtyMiliary tuberculosisTuberculosisAdolescentGeneral Biochemistry Genetics and Molecular BiologyDiagnosis DifferentialMycobacterium tuberculosisPredictive Value of TestsInternal medicineGastrointestinal infectionsmedicineHumansTuberculosisDiagnostic ErrorsEmerging infections Gastrointestinal infections Intestinal tuberculosis Mycobacterium tuberculosis TuberculosisTuberculosis MiliaryBiochemistry Genetics and Molecular Biology(all)business.industryMycobacterium tuberculosisAbdominal distensionmedicine.diseasebiology.organism_classificationSurgeryTuberculosis GastrointestinalTomography X-Ray Computedbusiness
researchProduct

Small bowel obstruction after laparoscopic gastrectomy: An atypical clinical presentation. Report of a case

2020

Abstract Introduction Postoperative adhesions represent the most common cause of acute small bowel obstruction (80%) and are usually a consequence of abdomino-pelvic surgery performed with open technique. Presentation of case A 45-year-old black man arrived at the emergency room with abdominal pain and distension three months after laparoscopic distal gastrectomy with Roux-en-Y anastomosis performed for benign pyloric stenosis. CT abdominal scan revealed some air-fluid levels in the center of the abdomen with distension of proximal jejunal loops caused by intestinal adhesions. Laparoscopic adhesiolysis was performed to restore the intestinal transit. Discussion The formation of adhesions is…

Abdominal painmedicine.medical_specialtyAdhesiolysismedicine.medical_treatmentCase ReportAnastomosisDistensionPyloric stenosis03 medical and health sciences0302 clinical medicineLaparotomymedicineLaparoscopyPostoperative adhesionsmedicine.diagnostic_testbusiness.industrySmall bowel obstructionmedicine.diseaseSurgeryBowel obstructionmedicine.anatomical_structure030220 oncology & carcinogenesisLaparoscopic gastrectomyAbdomenLaparoscopy030211 gastroenterology & hepatologySurgerymedicine.symptombusinessInternational Journal of Surgery Case Reports
researchProduct

Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive an…

2019

Background:Linaclotide is approved for the treatment of moderate-to-severe irritable bowel syndrome (IBS) with constipation (IBS-C) in adults. This study aimed to assess factors predictive of a clinical response and improvements in non-IBS symptoms with linaclotide treatment in a Spanish patient population.Methods:In this open-label phase IIIb study, patients with moderate-to-severe IBS-C received linaclotide 290 μg once daily for 12 weeks. The primary endpoint was clinical response at week 12, defined as >30% reduction in IBS symptom severity score (IBS-SSS) or IBS-SSS <75 plus self-reported response of feeling ‘better’ or ‘much better’ versus the baseline. Digestive nonintestinal an…

Abdominal painmedicine.medical_specialtyConstipation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinefunctional gastrointestinal diseasesmedicinelcsh:RC799-869LinaclotideIrritable bowel syndromeOriginal Researchirritable bowel syndromebusiness.industryGastroenterologyabdominal painconstipationmedicine.diseasechemistry030220 oncology & carcinogenesisSustained response030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. Gastroenterologymedicine.symptombusinessTherapeutic Advances in Gastroenterology
researchProduct